Lung Cancer
Volume 71, Issue 3 , Pages 319-322 , March 2011

Fluorescent in situ hybridization (FISH) in the differential diagnosis of ground-glass opacities in the lung

  • Daniela Bettio

      Affiliations

    • Cytogenetic Laboratory, Operative Unit of Clinical Investigations, IRCCS Humanitas Clinical Institute, Via Manzoni, 56, Rozzano, Milan 20089, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 02 82244722; fax: +39 02 82244790.
  • ,
  • Anna Venci

      Affiliations

    • Cytogenetic Laboratory, Operative Unit of Clinical Investigations, IRCCS Humanitas Clinical Institute, Via Manzoni, 56, Rozzano, Milan 20089, Italy
  • ,
  • Umberto Cariboni

      Affiliations

    • Department of Thoracic Surgery, IRCCS Humanitas Clinical Institute, Rozzano, Milan, Italy
  • ,
  • Mariagrazia Di Rocco

      Affiliations

    • Department of Pathology, IRCCS Humanitas Clinical Institute, Rozzano, Milan, Italy
  • ,
  • Maurizio Infante

      Affiliations

    • Department of Thoracic Surgery, IRCCS Humanitas Clinical Institute, Rozzano, Milan, Italy

Received 30 April 2010 ,Revised 16 June 2010 ,Accepted 18 June 2010.

References 

  1. Infante M, Lutman RF, Imparato S, Di Rocco M, Ceresoli GL, Torri V, et al. Differential diagnosis and management of focal ground-glass opacities. Eur Resp J. 2009;33:1–7
  2. Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS ELCAP Group. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol. 2002;178:1053–1057
  3. Nakata M, Saeki H, Takata I, Segawa Y, Mogami H, Mandai K, et al. Focal ground-glass opacity detected by low-dose helical CT. Chest. 2002;121:1464–1467
  4. Kitamura H, Kameda Y, Ito T, Hayashi H. Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. Am J Clin Pathol. 1999;111:610–622
  5. Travis W, Colby T, Corrin B, Shimosato Y, Brambilla E, Sobin LH. World health organization: histological typing of lung and pleural tumors. Berlin: Springer; 1999;pp. 28–40
  6. Bettio D, Giardino D, Rizzi N, Simoni G. Cytogenetic abnormalities detected by direct analysis in a case of choriocarcinoma. Cancer Genet Cytogenet. 1993;68:149–151
  7. Bettio D, Rizzi N, Giardino D, Persani L, Pecori-Giraldi F, Losa M, et al. Cytogenetic study of pituitary adenomas. Cancer Genet Cytogenet. 1997;98:131–136
  8. Shaffer LG, Tommerup N. ISCN 2005: an international system for human cytogenetic nomenclature. Basel: S. Karger; 2005;
  9. Sokolova IA, Bubendorf L, O’Hare A, Legator MS, Jacobson KK, Grilli BSB, et al. A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens. Cancer. 2002;96:306–315
  10. Halling KC, Rickman OB, Kipp BR, Harwood AR, Doerr CH, Jett JR. A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest. 2006;130:694–701
  11. Beasley M, Brambilla E, Travis W. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol. 2005;40:90–97
  12. Williams BR, Amon A. Aneuploidy: cancer's fatal flaw?. Cancer Res. 2009;69:5289–5291

PII: S0169-5002(10)00314-4

doi: 10.1016/j.lungcan.2010.06.014

Lung Cancer
Volume 71, Issue 3 , Pages 319-322 , March 2011